Core Insights - Repligen Corporation has announced a strategic partnership with Novasign to integrate machine learning and modeling workflows into its filtration systems, with Repligen investing in Novasign to support its operational expansion [1][2][4] Group 1: Partnership Details - The collaboration will integrate Novasign's modeling workflow into Repligen's tangential flow filtration (TFF) systems, enhancing digitalization and process analytical technology (PAT) capabilities [2][4] - The partnership aims to streamline process development, enable real-time predictive control, and reduce development timelines and costs through digital twin technology [2][3] Group 2: Company Profiles - Novasign, founded in 2019, specializes in bioprocessing modeling technology and aims to accelerate bioprocess development through smart workflows and modeling platforms [5] - Repligen Corporation is a global life sciences company focused on innovative bioprocessing technologies, serving biopharmaceutical developers and contract development organizations [6]